Takeda Pharmaceutical Co., Ltd. (TAK)
17.86
0.00 (0.00%)
USD |
NYSE |
Oct 02, 16:00
17.86
0.00 (0.00%)
Pre-Market: 20:00
Takeda Pharmaceutical Profit Margin (Quarterly) : 9.28% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.28% |
| March 31, 2026 | -33.66% |
| December 31, 2025 | 8.70% |
| September 30, 2025 | -1.05% |
| June 30, 2025 | 11.23% |
| March 31, 2025 | -9.79% |
| December 31, 2024 | 2.08% |
| September 30, 2024 | 7.83% |
| June 30, 2024 | 7.89% |
| March 31, 2024 | -0.28% |
| December 31, 2023 | 9.52% |
| September 30, 2023 | -4.60% |
| June 30, 2023 | 8.45% |
| March 31, 2023 | 3.26% |
| December 31, 2022 | 10.87% |
| September 30, 2022 | 6.16% |
| June 30, 2022 | 10.80% |
| March 31, 2022 | -1.30% |
| December 31, 2021 | 6.42% |
| September 30, 2021 | 5.44% |
| June 30, 2021 | 14.50% |
| March 31, 2021 | 25.59% |
| December 31, 2020 | 11.05% |
| September 30, 2020 | 0.52% |
| June 30, 2020 | 10.29% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.21% |
| December 31, 2019 | -3.74% |
| September 30, 2019 | 8.36% |
| June 30, 2019 | 0.83% |
| March 31, 2019 | -4.08% |
| December 31, 2018 | 7.58% |
| September 30, 2018 | 11.24% |
| June 30, 2018 | 17.36% |
| March 31, 2018 | -13.46% |
| December 31, 2017 | 13.93% |
| September 30, 2017 | 6.39% |
| June 30, 2017 | 32.35% |
| March 31, 2017 | -12.62% |
| December 31, 2016 | 9.12% |
| September 30, 2016 | 6.06% |
| June 30, 2016 | 23.12% |
| March 31, 2016 | -7.94% |
| December 31, 2015 | 12.34% |
| September 30, 2015 | 6.68% |
| June 30, 2015 | 5.70% |
| March 31, 2015 | -51.48% |
| December 31, 2014 | 3.93% |
| September 30, 2014 | 6.55% |
| June 30, 2014 | 8.34% |
| March 31, 2014 | -5.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sanofi | -- |
| Daiichi Sankyo Co., Ltd. | 11.94% |
| Ono Pharmaceutical Co., Ltd. | 20.80% |
| Astellas Pharma, Inc. | 22.12% |
| Eisai Co., Ltd. | 8.17% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.19% |
| Return on Assets | -1.07% |
| Return on Invested Capital | -1.32% |
| Gross Profit Margin (Quarterly) | 57.57% |
| Operating Margin (Quarterly) | 20.36% |
| Return on Net Operating Assets | -1.21% |